OpenAI acquires biotech AI startup Orchestra Bio to accelerate AI drug discovery
Polymarket · x · 2026-10-21
Polymarket reports that OpenAI has acquired biotech AI startup Orchestra Bio, accelerating its push into AI-driven drug discovery.
Related event: OpenAI Acquires Orchestra Bio to Push AI Agents into Drug Development(13 posts)→
More from Venture
- Ben Bajarin: $9.6T AI capex vs $4.1T revenue, but AI can still pay for itself — BenBajarin · 2026-10-21
- Gamebeast migrates a customer off PostHog in a day, pledges $50K MRR in 30 days — zanbrum · 2026-10-21
- Cloudflare's first Cold Start contest: Haelo Health wins $500k, Polylane takes $100k — threepointone · 2026-10-21
- DeepInfer math: 1GW of GB200 could generate $100B+ revenue at DeepSeek's current prices — bookwormengr · 2026-10-21
- Polymarket cites staggering $80 billion net loss for Anthropic in first half of 2026 — Polymarket · 2026-10-21
- Anthropic's new S-1 draft shows potential $750B compute spend, up from $518B — firstadopter · 2026-10-21